Search
for
Sort by
Community 17
- ICYMI: Eirion ET-02’s Successful Phase 1 Trial Results for Androgenic Alopecia Treatment
- "When comparing 5% minoxidil with 0.60 mm or 1.20 mm needle lengths, Faghihi et al. found that 0.60 mm needle lengths led to significant hair count and diameter increases versus 5% minoxidil, whereas 1.20 mm needle lengths only saw hair count increases versus 5% minoxidil"
- M37, Finasteride 1mg depuis 1 mois et 2 semaines. Minoxidil topique 5mg depuis aujourd’hui.
- How ET-02 Works. Also no proof that it's better than Minoxidil. At least for now.
- Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
- FCE 28260: A Forgotten 5α-Reductase Inhibitor
- 2 years of recovering & growing my hair
- Why does Pelage PP405 receive so much attention, while Eirion ET-02 seems to be almost forgotten?
- I hope ET-02 or PP405 will be released in the next 4-5 years
- Eirion ET-02( RS 5441) managed to defeat rodents, finally
- Community ranking on what new drugs/studies we are most hopeful about?
- If pp405 isnt the “cure” is there anything else that’s promising thats atleast better than min or dut?
- Why there are no updates from Amplifica about SCUBE3 & AMP-303?
- What new hair-loss treatments actually look exciting right now (Oct 2025)
- Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results
- Is 2.5MG of Dutasteride everyday basically guaranteed maintenance at the least?
- Dutasteride Infertility Debunked: Low T causes true infertility.